Life Sciences
Our Global Life Sciences sector can help you navigate forward and achieve sustainable success in the new health-outcomes-driven ecosystem.
Aging populations and chronic disease are putting pressure on health resources around the world just as scientific progress, augmented intelligence and digital data are transforming the traditional health care models. This is causing a power shift with new entrants (often not driven by profit) disrupting the incumbents.
Staying competitive and providing the personalized experience that patients demand require life sciences organizations to find new ways of working. Partnering with others to share data, medicine and resources while anticipating trends and regulatory changes will help ensure sustainability in the increasingly evidence-based, outcomes-focused sector.
We help companies across the biotechnology, pharmaceutical and medical technology fields harness this disruption by forming the right alliances, better allocating resources and building trust with customers.
![GenAI in pharma industry](https://assets.ey.com/content/dam/ey-sites/ey-com/en_in/topics/health/2024/ey-ai-health-technology.jpg.rendition.450.300.jpg)
How GenAI is revolutionizing the pharmaceutical industry
Our latest thinking on Life Sciences
How a global pharma leader saved INR500 cr trapped in receivables in India
Deploying a strong governance around AR management enabled the company to enhance its AR performance and implement stronger credit controls.
![Accounts Receivable Management (AR) use case](https://assets.ey.com/content/dam/ey-sites/ey-com/en_in/topics/health/2024/ey-case-study-image-featured-banner.jpg.rendition.450.300.jpg)
We designed a collections strategy to reduce overall aging AR.
The tracking system manages multiple aspects across processes and stakeholders.
![EY built and implemented a comprehensive forecasting tool.](https://assets.ey.com/content/dam/ey-sites/ey-com/en_in/topics/health/2023/08/ey-case-study-image-03.jpg.rendition.450.300.jpg)
Cross-functional effort and process improvement reduced AR.
The improved AR management enhanced company’s financial health, reinforcing its market standing.
![The new ERP improves processes and enables better decisions.](https://assets.ey.com/content/dam/ey-sites/ey-com/en_in/topics/health/2023/08/ey-case-study-image-04.jpg.rendition.450.300.jpg)
Meet our Life Sciences consulting team
Contact us
Like what you’ve seen? Get in touch to learn more.